January 19, 2017 5:45pm
Volatility takes its toll related directly to the sector’s credibility
Pre-open indication’s tally: 3 hit (AGTC, CYTX and PSTI) and 2 miss (BLCM and ONVO)
Out and about: Stemline Therapeutics (STML) proposes offering, no pricing or share amounts noticed. STML closed DOWN -$0.70 with 133.7K volume <3 month average = 164.3 K>. Jefferies LLC is acting as book-running manager for the offering. Pluristem (PSTI) announces specifics of offering - a minimum of 8.16 M shares at a price to the public of $1.225 per share together with 50% warrants, HC Wainright is manager.
Can you afford to miss the insider view … Click here for access and subscribe: http://www.regmedinvestors.com/create-account
Members only. Please login.